Health Mobius is proud to sponsor the “COVID-19: Starting a Testing Program” using a combination of rRT-PCR Test and the IgG/IgM Rapid Anti-body Test
This seminar is for pharmacies, HME, DME, hospital systems and large corporate entities interested in establishing a testing program for the patients, their community or their employees.
CoSo Health’s Diagnostic Testing
FDA UEA approved Covid-19 tests: Thermo Fisher Scientific TaqPathTM Covid-19 Combo Kit
A turn-key solution that includes:
- collection kits and universal transport medium (UTM)
- shipping supplies and overnight postage
- electronic ordering system for efficient and accurate ordering of covid-19 testing
- label printers for efficient and accurate sample identification
- Covid – 19 analysis of sample
- online results portal (cloud)
- client services support and dedicated account managers for each facility
- test results within 48 hours of receipt of sample
Sienna Rapid Test
FDA UEA approved Covid-19 tests
The Sienna COVID-19 IgG/IgM Rapid Test Cassette is a membrane-based lateral flow immunoassay intended for the qualitative detection of SARS-CoV-2 antibodies in human whole blood, serum, or plasma (EDTA, citrate, heparin). The Sienna COVID19 IgG/IgM Rapid Test Cassette is intended for use as an aid in identifying patients with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection.
- Received EUA Authorization in July 2020
- Manufactured in Finland with ZERO components from CHINA
- Only Antibody Rapid Test that comes with 20 tests and 20 reagents/buffers per kit
- Combined Sensitivity 93.3%
- Combined Specificity 98.8%
LDRR International Holdings, LLC
Tom is the Co-Founder and managing Director at LDRR International Holdings, LLC which was founded with a focus on Leadership, Determination, Resilience, and Responsibility (thus the name LDRR). LDRR is an aggregator of best in class products for testing and protection against COVID-19 and other viral and bacterial diseases. We are committed to partnering with global companies who are researching, developing, and producing disruptive and cutting-edge technologies. The solutions that we represent are evidence-based and our mission is to deliver them at affordable pricing and within reach of all people. LDRR has partnered with the industry leading USA and European Manufacturers of COVID-19 IgG/IgM Rapid Test Kits (both serology and molecular PCR tests), and other diagnostic solutions for the qualitative detection of COVID-19 antibodies. LDRR is continuously expanding their offerings to include comprehensive COVID-19 response solutions and platforms to address the way diseases and conditions are identified, tracked and managed, enabling medical operators to better assess treatment paths and allowing restarting of businesses and society so that individuals may return to work, school or other activities.
Chris Longacre is an attorney and government affairs professional with twenty years of experience. She started her career working for the Chair of the New York State Assembly’s Corporations and Authorities Committee. Chris has worked in many different industries including the beer industry, auto industry and sports entertainment. Some of her positions include National Manager of Government Affairs of the United States Tennis Association (USTA) and Director at the New York Yankees. Over the past five years, Chris has worked in the healthcare industry for hospitals in the space of liability serving as Executive Director of Coloradans Protecting Patient Access. Chris is a graduate of the University of Colorado – Boulder and University of Denver Sturm College of Law.